Research In China, Sep 2010, Pages: 121
products, taking the core position in the globalbiotechnology industry. Now, nearly 60% of biotechnology patents are held by USA.
At present, there are more than 700 companies in China’s biological and bio
Research In China, Sep 2010, Pages: 121
products, taking the core position in the globalbiotechnology industry. Now, nearly 60% of biotechnology patents are held by USA.
At present, there are more than 700 companies in China’s biological and bio
MP Advisors, Jan 2012, Pages: 130
Global Biopharma Outlook 2012 - Rising Stars and Mature Biotech Global Biopharma Outlook 2012: Rising stars and Mature Biotech
The Rising Stars (non-profitable biotech/ biopharma companies) chapter
Markets and Markets, Sep 2009, Pages: 107
Neurostimulation - Advanced Technologies andGlobal Market (2009 - 2014) The global market for neurostimulation products is expected to be worth $3.6 billion in 2009, growing at a CAGR of 22.7
MP Advisors, Jan 2012, Pages: 109
Global Biopharma Outlook 2012 - Major US and EU Pharma Global Biopharma Outlook 2012 –Major US and EU Pharma
Unarguably 2011 was one of the very good years for the global Pharma industry as the
Frost & Sullivan, Dec 2008, Pages: 96
Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical andBiotechnology Markets This strategic analysis identifies the current trends in scientific business
Frost & Sullivan, Dec 2006, Pages: 96
, fatty acids, and proteins, and to create new jobs, enhance income, and enable high returns of the use of natural resources, makes it an important tool to combat global poverty and hunger. "However, it is
Frost & Sullivan, Jan 2007, Pages: 65
examine the following markets: safety lancets and personal/homecare lancets Increasing Incidence of Diabetes and Growing Need for POCT to Promote Demand for Lancets
On a global level, lancets are being
Cambridge Healthtech Institute, Sep 2005, Pages: 180
The Global GCP Compliance Report 2006: US, EU, and Japan The First-Ever Study of Global GCP Clinical Trial Compliance Programs and Trends! Learn what the FDA, EMEA, OHRP, and Japan’s PMDA see as the
Jain PharmaBiotech, June 2012, Pages: 354
Animal Biotechnology - Technologies, Markets and Companies This report describes and evaluates animal biotechnologyand its application in veterinary medicine andpharmaceuticals as well as
Global Industry Analysts, Inc., Jan 2012, Pages: 281
Biotechnology - Global Outlook The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers
Taiyou Research, June 2011, Pages: 430
well and has become the new engine of the global economy.
The products derived through biotechnology have altered the landscape of many industries, particularly pharmaceuticals. The completion of the
Global Industry Analysts, Inc., Oct 2010, Pages: 274
, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics
Decision Resources, Inc., Sep 2009, Pages: 36
A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma Industry The biotechnologyand pharmaceutical sectors as we know them will soon cease to exist
MarketLine, Feb 2010, Pages: 102
in 2008, representing a compound annual growth rate (CAGR) of 17.9% for the period spanning 2004-2008.
- The globalpharmaceuticals, biotechnology, and life sciences industry group generated total
Global Industry Analysts, Inc., Jan 2011, Pages: 266
Marine Biotechnology - Global Strategic Business Report This report analyzes the Global markets for Marine Biotechnology in US$ Million by the following product segments- Marine Biomaterials, Marine
Datamonitor, March 2011, Pages: 111
Pharmaceuticals, PharmaceuticalsandPharmaceuticals, Biotechnology & Life Sciences
Highlights
The globalbiotechnology market had total revenue of $200 billion in 2009, representing a compound annual growth rate
